Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIAO@TBI: Complement Inhibition After Traumatic Brain Injury
2024-514488-24-02Phase 2Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of c1-esterase inhibitor in traumatic brain injury (TBI) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Therapy Intensity Level Scale. Planned start Oct 2024; status: authorised.
02
Drugs
c1-esterase inhibitor
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2024-514488-24-02.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514488-24-02.